Alterations of insulin secretion in familial combined hyperlipidemia;Alteración de la secreción de insulina en la hiperlipermia familiar combinada

Medicina Clinica

Volumn 108, Issue 14, 1997, Pages 530-533

  Ascaso, Juan Francisco ^a,b   Sales, Jorge ^a   Priego, Antonia ^a   Merchante, Ángel ^a   Carmena Ramón, Rafael ^a   Carmena, Rafael ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPID; LIPOPROTEIN;

ADULT; ARTICLE; BLOOD; BODY WEIGHT; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FAMILIAL HYPERLIPEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINISM; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; SECRETION;

ADULT; BLOOD GLUCOSE; BODY WEIGHT; CORONARY DISEASE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; HYPERLIPIDEMIA, FAMILIAL COMBINED; INSULIN; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0031565394     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Goldstein JL, Hazzard WR, Schrott G, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 1973; 52: 1.533-1.543.
2. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky HG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1.544-1.568.
3. Hazzard WR, Goldstein JL, Schrott HG, Motulsky AG, Bierman EL. Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction. J Clin Invest 1973; 52: 1.569-1.577.
4. Nikkila EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart disease. Lancet 1973; 1: 954-958.
5. Rose HG, Kranz P, Weistck M, Juliano J, HAft JI. Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype. Am J Med 1973; 54: 148-160.
6. Glueck CJ, Fallat CR, Buncher R, Tsang R, Steiner P. Familial combined hyperlipoproteinemia: studies in 91 adults and 95 children form 33 kindreds. Metabolism 1973; 22: 1.403-1.428.
7. Brunzell JD, Schrott HG, Motulsky AG, Bierman EL Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 1976; 25: 313-320.
8. Genest J Jr, Familial combined hyperlipoproteinemia. Can Med Assoc J 1991; 145: 664.
9. Williams RR, Hopkins PN, Hunt SC, Wu LL, Hasstedt SJ, Lalovel JM, Ashko Ko. Population-based frecuency of dyslipemia syndromes in coronary-prone families in Utha. Arch Intern Med 1990; 150: 582-588.
10. Rose HG, Kranz P, Weinstock M, Juliano J, Haft JI. Combined hyperlipoproteinemia. Evidence for a new lipoprotein phenotype. Atherosclerosis 1974; 20: 51-64.
11. a ed.). Madrid: Mosby/Doyma, 1995; 1.899-1.922.
12. Iverius PH, Brunzell JD. Obesity and common genetic disorders. Ann Intern Med 1985; 103: 1.050-1.051.
13. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME et al. Apolipoprotein, low density lipoprotein subraction, and insulin associations with familial combined hyperlipidemia. Arteriosclerosis 1989; 9: 335-344.
14. Ascaso JF, Serrano S, Martínez-Valls J, Hernández A, DeLera, Carmena R. Plasma lipoproteins in familial combined hyperlipidemia: a study of hyperlipemic and normolipidemic kindreds. Nutr Metab Cardiovasc Dis 1992; 2: 165-169.
15. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Bus-selton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154-160.
16. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease; results from two population studies in Finland. Diabetes Care 1979; 2: 131-141.
17. Dicimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980; 19: 205-210.
18. Laws A, King AC, Haskell WL, Reaven GM. Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men. Arterioscl Thromb 1991; 11: 1.636-1.542.
19. Ferranini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
20. Ronnemaa T, Laakso M, Pyörälä K, Kallio V, Puukka P, High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetc patients and nondiabetic subjects. Arterioscler Thromb 1991; 11: 80-90.
21. Erikcsson J, Franssilla-Kallunki A, Edstrand A, Saloranta C, Widen E, Schalin C et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337-343.
22. Terry RB, Wood PD, Haskell WL, Stefanick ML, Krauss RM. Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction in men. J Clin Endocrinol Metabol 1989; 68: 408-411.
23. King GL, Goodman AD, Buzney S, Moses A, Kahn CR. Receptors and growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985; 75: 1.028-1.036.
24. Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care 1990; 13: 631-654.
25. Allain CC, Poon LS, Chan CSG, Richmod W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1979; 20: 470-475.
26. Ter HF, Baarscheer T, Fiolet JWT. Influence of free glycerol on enzymatic of trigylcerides. Clin Chem 1984; 30: 1.102-1.103.
27. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lip Res 1970; 11: 583-595.
28. Havel RJ, Eder HJ, Bragdon JH. The distribution and chemical composition of ultracentrifugally separed lipoproteins in human serum. J Clin Invest 1955; 34: 1.345-1.354.
29. Rosseneau M, Verchemst R, Steinberg KK, Cooper GR. Some considerations of methodology and standaritation of apolipoprotein B inmunoassays. Clin Chem 1983; 29: 427-433.
30. National Diabetes Data Group. Report of an Expert Committee on Diabetes. Bethesda: National Institutes of Health, 1985.
31. Trinder P. Enzimatic colorimetric method for glucose determination. Ann Clin Biochem 1969; 6: 24-27.
32. Berson S, Yellow RS. Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 1959; 38: 1.996-2.016.
33. Statgraphics Plus 1.0. Statistical Graphic Corp. 1994.
34. Brunzell JD, Austin MA, Deeb SS, Hokanson JE, Jarvic GP, Nevin DN et al. Familial combined hyperlipidemia and genetic risk for atherosclerosis. En: Woodford FF, Davignon J, Suiderman A, editores. Atherosclerosis X. Amsterdam: Elsevier Science BV, 1995; 624-627.
35. Hokanson JE, Austin MA, Zambon A, Brunzell JD. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler Thromb 1993; 13: 427-434.
36. Venkatasan S, Cullen P, Pacy P, Halliday D, Scott J. Stable isotopes show a direct relation between VLDL apo B overproduction an serum triglycerice levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 1993; 13: 1.110-1.118.
37. Castro-Cabezas M, De Bruin TW, De Walk HW, Shoulderns CC, Jansen H, Willem-Erkelens D. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest 1993; 92: 160-168.
38. Griffin BA, Freeman DJ, Tait GW, Thomson J, Casleke MJ, Packard CJ, Sheperd J. Role of plasma triglyceride in the regulation of plasma LDL subfraction: relative contribution of small dense LDL to CHD risk. Atherosclerosis 1994; 106: 241-253.
39. Mykkanen L, Kuusisto J, Haffner SM, Pyorala K, Laakso M. Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscl Thromb 1994; 14: 518-526.
40. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993; 92: 141-146.
41. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer J et al. LDL subclases phenotypes and the insulin resistance syndrome in women. Circulation 1993; 88: 381-387.
42. Hunt SC, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM et al. Apolipoprotein, low density lipoprotein subfraction and insulin asociation in familial combined hyperlipidemia. Arteriosclerosis 1989; 9: 335-344.
43. Karhapää P, Voutilainen E, Malkki M, Laakso M. Obese man with type IIB hyperlipidemia are insulin resistant. Arterioscler Thromb 1993; 13: 1.469-1.475.
44. Sijbrands EJG, Westendorp RGJ, Hoffer MJV, Havekes LM, Frants RR, Meinders AF et al. Effect of insulin resistance, apo E2 allele and smoling on combined hyperlipidemia. Arterioscler Thromb 1994; 14: 1.576-1.580.